Rivaroxaban CAS 366789-02-8 Purity > 99.5% (HPLC) Hoobkas API Siab Zoo
Chaw tsim tshuaj paus Supply Rivaroxaban Related Intermediates:
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0
4-(4-Aminophenyl) morpholin-3-one CAS 438056-69-0
Rivaroxaban Intermediate CAS 446292-07-5
5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6
5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9
Rivaroxaban API CAS 366789-02-8
Tshuaj npe | Rivaroxaban |
Synonyms | (S)-Rivaroxaban;(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;PAB 59-7939 |
CAS Nr | 366789-02-8 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C19H18ClN3O5S |
Molecular Luj | 435.88 ib |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Dawb los yog Yuav luag Dawb Hmoov |
Kev Taw Qhia A | Kev nqus infrared ntawm Rivaroxaban sib haum rau cov qauv siv |
Kev Qhia B | Lub sijhawm khaws cia ntawm lub ntsiab ncov ntawm cov qauv kev daws teeb meem sib raug rau qhov kev daws teeb meem tsim nyog, raws li tau txais hauv enantiomeric purity. |
Enantiomeric Purity yog qhov zoo | RVX RC01: ≤0.15% |
Moisture (KF) | ≤0.50% |
Sulfated tshauv | ≤0.10% |
Hnyav Hlau | ≤ 20ppm |
Acetic acid | ≤5000ppm |
Yam khoom (HPLC) | |
RVX RC02 | ≤ 0.15% |
TSI RC03 | ≤ 0.15% |
TSI RC04 | ≤ 0.15% |
TSI RC05 | ≤ 0.15% |
TSI RC06 | ≤ 0.15% |
TSI RC07 | ≤ 0.15% |
TSI RC08 | ≤ 0.15% |
Lwm Tus Neeg Tsis Pom Zoo | ≤0.10% |
Tag nrho cov impurities | <0.50% |
Residual Solvents (GC) | |
Ethanol | ≤5000ppm |
Toluene | ≤890ppm |
Triethylamine | ≤320ppm |
Purity / Analysis Method | > 99.5% (HPLC) (raws li anhydrous hauv paus) |
Test Standard | Enterprise Standard |
Kev siv | API;Tshuaj Antithrombotic;FXa Inhibitor |
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj.
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.
Rivaroxaban(CAS:366789-02-8) (Xarelto, Bayer) yog ib qho tshuaj tiv thaiv qhov ncauj.Nws yog qhov ncauj qhov ncauj ncaj qha cuam tshuam Xa inhibitor.Rivaroxaban yog qhia rau 'kev kho mob ntawm cov hlab ntsha sib sib zog nqus thrombosis thiab pulmonary embolism, thiab kev tiv thaiv ntawm recurrent deep vein thrombosis thiab pulmonary embolism nyob rau hauv cov neeg laus'.Rau thawj zaug kev kho mob ntawm mob ntsws embolism, qhov pom zoo koob tshuaj ntawm rivaroxaban yog 15 mg ob zaug ib hnub twg rau thawj 21 hnub tom qab 20 mg ib hnub ib zaug rau kev kho mob txuas ntxiv thiab tiv thaiv kev rov tshwm sim ntawm venous thromboembolism.Tsis-Valvular Atrial Fibrillation (NVAF) los tiv thaiv mob stroke & systemic embolism.Kev kho mob VTE & tiv thaiv kev rov tshwm sim ntawm VTE [rau qhov sib sib zog nqus hlab ntsha thrombosis (DVT) thiab pulmonary embolism (PE)].Kev tiv thaiv ntawm venous thromboembolic xwm txheej (VTE) hauv kev xaiv tag nrho lub duav lossis lub hauv caug hloov phais (THR, TKR).